A schematic approach to a patient with suspected RS

Slides:

Advertisements

Similar presentations

All About HIV…. BY: Keana Butler. So you say your infected with HIV??, Huh..what is it??? It’s a immunodeficiency virus that weakens the body immune system.

Advertisements

A Sore Throat Your patient is a 5-year-old boy who awoke on the day prior to evaluation with a sore throat and fever. His mother had him stay home from.

Hodgkin lymphoma Histologic subtypes: - Nodular sclerosing - Mixed cellularity - Lymphocyte predominance -Lymphocyte depleted new category: - Lymphocyte.

Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.

LEUKEMIA. What Is It? Leukemia is a type of cancer that starts in the tissue that forms blood.

Pluripotent hematopoietic stem cells are common ancestral cells for all blood and immune cells.

Dan Lauser Period 1.  Leukemia is cancer of the blood cells. It causes many problems and is very dangerous. This disease causes the bone marrow(the part.

Lymphoma Symptoms Lumps over your body. Weight Loss Fever Sweat at night Itch Loose appetite Weak Swollen neck and face.

How to manage suspected cancer

Hodgkin’s Lymphoma By: Tonya Weir and Paige Mathias Date: October 13, 2010.

Lymphoma- All you Need to know in ONE hour Cathleen Cook Pediatric Hematology/ Oncology March 12, 2014.

1 Nursing Care of Patients with Hematologic Disorders.

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,

Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Taylor Edwards. What is Leukemia? Leukemia is a type of blood cancer that begins in the bone marrow. The bone marrow starts making abnormal white blood.

Leukemia Cancer of WBC’s Starts in bone marrow

Hematology and Hematologic Malignancies

LYMPHOMA Malignant transformation of cell in Lymphatic system There are about 600 Lymph Nodes in the body Spleen and gut also have lymphatic tissue.

Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.

APPROACH TO LYMPHOID MALIGNANCIES. Patient Evaluation of ALL Careful history and PE CBC Chemistry studies Bone marrow biopsy Lumbar puncture.

Week 6 BGD: Discussion on Hodgkin’s Lymphoma (Etiology, Immunology, Clinical Features, Staging Evluation, Treatment) Presented to the Department of Medicine.

Leukemia & Lymphoma Society. Coby’s Story  17 months old  3 years 2 months Chemotherapy  20 hospital admissions  100 days at Lutheran General Hospital.

Hodgkin’s Lymphoma Hodgkin’s Lymphoma Disease in which malignant (cancer) cells form in the lymph system Type of cancer that develops in.

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis by Katharine H.

Leukemia & Lymphoma Society. Coby’s Story  17 months old  3 years 2 months Chemotherapy  20 hospital admissions  100 days at Lutheran General Hospital.

..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.

By: Ashlynn Hill. Patrice Thompson  3 year who is battling leukemia.  The doctors suggest a bone marrow transplants for a long term survival.  Neither.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Case 9 A 55 year old male presented with an enlarged axillary lymph node. Staging identified multiple enlarged lymph nodes, and B symptoms, including night.

Leukemia An estimate reveals over 327,520 people in the U.S. are living with Leukemia. In India leukemia is ranked among the list of top cancers affecting.

Rob Corbett NCCN Christchurch

Fig year-old man with CLL and transformation to DLBCL. A

A-I. MD Anderson Cancer Center algorithms for Hodgkin lymphoma

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

Finding a diamond in the (mouse is) rough

Next-generation leukemia immunotherapy

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

How I treat elderly patients with myeloma

Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing by Sandra Preuner, Renate Kastner,

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Parasternal mass Blood Volume 113(6): February 5, 2009

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome by Kerry J.

Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II by W.K. Hofmann, J.P. Kaltwasser,

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Primary testicular lymphoma

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Leukemia An estimate reveals over 327,520 people in the U.S. are living with Leukemia. In India leukemia is ranked among the list of top cancers affecting.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

Plasma biomarker concentrations between study groups.

by Wendy Lim, Sara K. Vesely, and James N. George

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Treatment algorithm for management of CRS based on the revised CRS grading system. Treatment algorithm for management of CRS based on the revised CRS grading.

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Biology and treatment of Richter syndrome

A and B, CT images on a patient status post total thyroidectomy for thyroid cancer show a small enhancing lesion near the right tracheoesophageal groove.

Schematic representations of pulmonary hypertension.

Patient Tregs express normal levels of suppression.

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

A, Postcontrast T1-weighted MR image of the brain during metastatic work-up demonstrates no metastatic disease. A, Postcontrast T1-weighted MR image of.

Cold agglutinin disease

MR images show capsular and cortical lesions (panels 6 and 7); schematic distributions of the lesions are presented. MR images show capsular and cortical.

Presentation transcript:

A schematic approach to a patient with suspected RS A schematic approach to a patient with suspected RS. *Signs and symptoms suspicious for transformation include: B-type symptoms (weight loss, night sweats, and fever), rapid enlargement of lymph nodes or spleen, hypercalcemia, and increased lactate dehydrog... A schematic approach to a patient with suspected RS. *Signs and symptoms suspicious for transformation include: B-type symptoms (weight loss, night sweats, and fever), rapid enlargement of lymph nodes or spleen, hypercalcemia, and increased lactate dehydrogenase. ABVD, doxorubicin, bleomycin, vinblastine, and dacarbazine. Sameer A. Parikh et al. Blood 2014;123:1647-1657 ©2014 by American Society of Hematology